The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Which patients with pre-treated locally advanced or metastatic sarcoma benefit most from trabectedin treatment: First results of a retrospective study of the German Interdisciplinary Sarcoma Group (GISG-14 - ReTraSarc).
 
Daniel Pink
Consulting or Advisory Role - Clinigen Group (Inst); Lilly (Inst); Roche (Inst)
Research Funding - Clinigen Group (Inst); Lilly (Inst); Novartis (Inst); PharmaMar (Inst); Roche (Inst)
 
Adrian Richter
No Relationships to Disclose
 
Dimosthenis Andreou
Honoraria - Lilly
 
Stephan Richter
Consulting or Advisory Role - PharmaMar
Travel, Accommodations, Expenses - PharmaMar
 
Anne Flörcken
Honoraria - Bayer; Bristol-Myers Squibb; Ipsen; Pfizer
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Ipsen; Pfizer
 
Christoph Deinzer
No Relationships to Disclose
 
Bernd Kasper
Honoraria - Bayer; Lilly; Novartis; Pfizer; PharmaMar
Consulting or Advisory Role - Bayer; ClinGen; Eisai; Lilly; Roche; SpringWorks Therapeutics
Research Funding - PharmaMar (Inst)
Travel, Accommodations, Expenses - Lilly; PharmaMar
 
Gerlinde Egerer
Stock and Other Ownership Interests - Pfizer
Honoraria - PharmaMar
Consulting or Advisory Role - Lilly
Speakers' Bureau - MSD; Pfizer; PharmaMar
 
Philipp Ivanyi
Travel, Accommodations, Expenses - PharmaMar
 
Armin Tuchscherer
Travel, Accommodations, Expenses - PharmaMar
 
Torsten Kessler
No Relationships to Disclose
 
Markus Schuler
No Relationships to Disclose
 
Christian Schmidt
No Relationships to Disclose
 
Jeannette Bahr
No Relationships to Disclose
 
Till Ittermann
No Relationships to Disclose
 
Peter Reichardt
Honoraria - Amgen; Bayer; Lilly; Novartis; Pfizer; PharmaMar
Consulting or Advisory Role - Bayer; Clinigen Group; Deciphera; Lilly; Novartis; Pfizer; PharmaMar; Roche
Research Funding - Novartis (Inst)